Cover
Vol. 14 No. 1 (2024)

Published: June 30, 2024

Pages: 10-29

Research Article

Effect of Follicular Fluid and Serum Irisin on Oocyte and Embryo Quality in PCOS Women Undergoing ICSI Cycle.

Sundus A. Dawood 1 Hayder A. L. Mossa Mufeda A. Jwad
1High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al Nahrain University, Baghdad, Iraq.
History
  • Received: February 7, 2024
  • Accepted: April 30, 2024
  • Available Online: June 10, 2024
DOI

https://doi.org/10.28969/IJEIR.v14.i1.r2.24

Abstract

Polycystic ovarian syndrome (PCOS) is a group of clinically distinct endocrine conditions. Insulin resistance-related proteins are involved in PCOS pathogenesis. Irisin is a new myokine that functions similarly to adipokines. Irisin has been linked to insulin resistance and metabolic syndrome. There have been conflicting findings regarding irisin levels and their connection to hormonal and metabolic alterations in PCOS .This study aimed to compare the levels of irisin in follicular fluid and serum between women with PCOS and healthy women and correlate them with oocyte and embryo quality in women undergoing the ICSI cycle .Ninety infertile Iraqi women were enrolled, 46 women with PCOS and 44 weight-matched non-PCOS controls, in whom ICSI was done for them and evaluated the level of follicular fluid, serum Irisin, and insulin level with measure of Homeostasis Model of Assessment-Insulin Resistance (HOMA-IR) and correlate them to with oocyte and embryo quality. HOMA-IR, FF, and serum irisin levels in PCOS considerably increased. (P ≤ 0.01). In addition, there was a significant negative correlation between Irisin levels in follicular fluid and serum with MII oocyte, oocyte maturity rate, and grade 1 embryo. The serum, follicular fluid Irisin, and HOMA-IR were significantly higher in PCOS than in control cases, which may cause a reduction in oocyte maturation, embryo quality, and pregnancy outcome.

Keywords

References

  1. Mohammad S, Faruque O, Lipa J, Chowdhury H, Khanom S, Faria S, et al. Clinical approach to infertile women and the vitro fertilization (IVF): a medicinal discipline chronicles. (Academy of Hospital Administration. 2022 Apr, 8(04):28–43. DOI:10.17605/OSF.IO/PV6QT
  2. Zhang L, Fang X, Li L, Liu R, Zhang C, Liu H, Tan M, Yang G. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome. J Endocrinol Invest. 2018 Dec;41(12):1401- 1407. DOI: 10.1007/s40618-018-0902-4.
  3. Wiweko B, Indra I, Susanto C, Natadisastra M, Hestiantoro A. The correlation between serum AMH and HOMA- IR among PCOS phenotypes. BMC Res Notes. 2018 Feb 9;11(1):114. DOI: 10.1186/s13104-018-3207-y.
  4. Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020 May;35:100937. DOI: 10.1016/j.molmet.2020.01.001. .
  5. Basukala P, Jha, B, Yadav BK & Shrestha, PK. Determination of Insulin Resistance and Beta-Cell Function Using Homeostatic Model Assessment in Type 2 Diabetic Patients at Diagnosis. Journal of Diabetes & Metabolism. 2018 Jan. 9(3). DOI:10.4172/2155-6156.1000790.
  6. Ibrahim M, Ahmed S, Abdel Moety D, Elsayed S. The relation of serum irisin level with metabolic and hormonal changes in rat model of polycystic ovary. Zagazig Univ Med J. 2018;24(5):409–19. DOI:10.21608/ZUMJ.2018.13266
  7. Fukushima Y, Kurose S, Shinno H, Cao Thi Thu H, Tamanoi A, Tsutsumi H, Hasegawa T, Nakajima T, Kimura Y. Relationships between serum irisin levels and metabolic parameters in Japanese patients with obesity. Obes Sci Pract. 2016 Jun;2(2):203-209. DOI: 10.1002/osp4.43.
  8. Mahgoub MO, D'Souza C, Al Darmaki RSMH, Baniyas MMYH, Adeghate E. An update on the role of irisin in the regulation of endocrine and metabolic functions. Peptides. 2018 Jun;104:15-23. DOI: 10.1016/j.peptides.2018.03.018.
  9. Jiang S, Piao L, Ma EB, Ha H, Huh JY. Associations of Circulating Irisin with FNDC5 Expression in Fat and Muscle in Type 1 and Type 2 Diabetic Mice. Biomolecules. 2021 Feb 20;11(2):322. DOI: 10.3390/biom11020322.
  10. Ma EB, Sahar NE, Jeong M, Huh JY. Irisin Exerts Inhibitory Effect on Adipogenesis Through Regulation of Wnt Signaling. Front Physiol. 2019 Aug 22;10:1085. DOI: 10.3389/fphys.2019.01085.
  11. Bousmpoula A, Benidis E, Demeridou S, Kapeta-Kourkouli R, Chasiakou A, Chasiakou S, Kouskouni E, Baka S. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles. Gynecol Endocrinol. 2019 Sep;35(9):803- 806. DOI: 10.1080/09513590.2019.1594761.
  12. Magaton IM, Helmer A, Eisenhut M, Roumet M, Stute P, von Wolff M. Oocyte maturity, oocyte fertilization and cleavage- stage embryo morphology are better in natural compared with high-dose gonadotrophin stimulated IVF cycles. Reprod Biomed Online. 2023 Apr;46(4):705-712. DOI: 10.1016/j.rbmo.2022.11.008.
  13. Zhang Y, Li Z, Ren B, Wu W, Liu Y, Wang X, Guan Y, Jia L. Diagnostic value of a single β-hCG test in predicting reproductive outcomes in women undergoing cleavage embryo transfer: a retrospective analysis from a single center. Reprod Health. 2022 Jun 22;19(1):145. DOI: 10.1186/s12978-022-01455-1.
  14. Yoon J, Jung D, Lee Y, Park B. The Metabolic Score for Insulin Resistance (METS-IR) as a Predictor of Incident Ischemic Heart Disease: A Longitudinal Study among Korean without Diabetes. J Pers Med. 2021 Jul 28;11(8):742. DOI: 10.3390/jpm11080742.
  15. Jassim WH, Al-Obaidi T, Abdulhameed WA. The Effect of Insulin Resistance on Oocyte Maturation and Embryo Quality in PCOS Patients Undergoing ICSI. Int J Pharm Phytopharm Res. 2019 Feb. 9(1):36–43. https://eijppr.com/fmH9voz
  16. Uk A, Decanter C, Grysole C, Keller L, Béhal H, Silva M, Dewailly D, Robin G, Barbotin AL. Polycystic ovary syndrome phenotype does not have impact on oocyte morphology. Reprod Biol Endocrinol. 2022 Jan 5;20(1):7. DOI: 10.1186/s12958-021-00874-2.
  17. Jain N, Malik S, Prakash V. Impact of various PCOS phenotypes on oocyte competence in an ART cycle. Clin J Obstet Gynecol. 2022; 5: 067-071. DOI: 10.29328/journal.cjog.1001110
  18. Artini PG, Malacarne E, Tomatis V, Genazzani AD. The relevance of inositols treatment for PCOS before and during ART. Eur Rev Med Pharmacol Sci. 2021 Jul;25(14):4799-4809. DOI: 10.26355/eurrev_202107_26393.
  19. Sharan B, Sagili H, Kamalanathan SK, Lakshminarayanan S. Serum Irisin Levels and its Association with Blood Glucose and Insulin Indices in Diagnosing Insulin Resistance in Adolescents with Polycystic Ovarian Syndrome. J Hum Reprod Sci. 2021 Apr-Jun;14(2):137-143. DOI: 10.4103/jhrs.jhrs_191_20. Epub 2021 Jun 28.
  20. Kruszewska J, Laudy-Wiaderny H, Kunicki M. Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open. Int J Environ Res Public Health. 2022 Feb 13;19(4):2099. DOI: 10.3390/ijerph19042099. PMID: 35206286;
  21. Furino VO, Alves JM, Marine DA, Sene- Fiorese M, Rodrigues CNDS, Arrais-Lima C, Mattiello SM, de Castro CA, Borra RC, Rocha MC, Malavazi I, Duarte ACGO. Dietary Intervention, When Not Associated With Exercise, Upregulates Irisin/FNDC5 While Reducing Visceral Adiposity Markers in Obese Rats. Front Physiol. 2021 Aug 13;12:564963. DOI: 10.3389/fphys.2021.564963.
  22. Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021 May;137:111315. DOI: 10.1016/j.biopha.2021.111315.
  23. Villareal R, Stocker CJ, Feraco A, Covasa M, Arhire LI, Mihalache L. Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome. Front Endocrinol. 2019;1:524. DOI:10.3389/fendo.2019.00524
  24. Mubarak SMH, Ali HA. Is irisin a phenotypic parameter in over-weight women with polycystic ovary syndrome? Medico- Legal Updat. 2020;20(2):455–60.
  25. Berberoğlu h, hacişevki a. An overview of the effects of irisin on metabolic disorders. Gazi sağlık bilim derg. 2021;2021(2):33–41. DOI:10.52881/gsbdergi.861600
  26. Foda AA, Foda EA, Abel-Aal I. Serum Irisin levels as a marker in some phenotypes of PCOS. Middle East Fertil Soc J. 2018 Jun. 23(2):112–6. DOI.org/10.1016/j.mefs.2017.09.005
  27. Leustean L, Preda C, Teodoriu L, Mihalache L, Arhire L, Ungureanu MC. Role of irisin in endocrine and metabolic disorders—possible new therapeutic agent? Appl Sci. 2021 Jun. 11(12):5579. DOI.org/10.3390/app11125579
  28. Chang CL, Huang SY, Hsu YC, Chin TH, Soong YK. The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients. Sci Rep. 2019 Apr 23;9(1):6447. DOI: 10.1038/s41598-019-42061-9.
  29. Zhang R, Fu T, Zhao X, Qiu Y, Hu X, Shi H, Yin X. Association of Circulating Irisin Levels with Adiposity and Glucose Metabolic Profiles in a Middle-Aged Chinese Population: A Cross-Sectional Study. Diabetes Metab Syndr Obes. 2020 Oct 30;13:4105-4112.
  30. Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, Tsoukas MA, Geladari EV, Huh JY, Dincer F, Davis CR, Crowell JA, Mantzoros CS. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013 Dec;98(12):4899-907.
  31. Wanderley MDS, Pereira LCR, Santos CB, Cunha VSD, Neves MVJ. Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients. Rev Bras Ginecol Obstet. 2018 Apr;40(4):188-195.
  32. Kim JJ, Hwang KR, Oh SH, Chae SJ, Yoon SH, Choi YM. Prevalence of insulin resistance in Korean women with polycystic ovary syndrome according to various homeostasis model assessment for insulin resistance cutoff values. Fertil Steril. 2019 Nov;112(5):959-966.e1. DOI: 10.1016/j.fertnstert.2019.06.035.
  33. Wang C, Zhang XY, Sun Y, Hou XG, Chen L. Higher circulating irisin levels in patients with polycystic ovary syndrome: a meta-analysis. 2017 Apr, 34(4):290–3. DOI/abs/10.1080/09513590.2017.1393065
  34. Farhan FS, Hussien SS. Irisin as a Novel Marker for Insulin Resistance in Iraqi Women with Polycystic Ovary Syndrome Before and After Metformin Therapy. J Obstet Gynaecol India. 2019 Oct;69(Suppl 2):194-200. DOI: 10.1007/s13224-018-1176-7.
  35. Zhu Y, Qi Z, Ding S. Exercise-Induced Adipose Tissue Thermogenesis and Browning: How to Explain the Conflicting Findings? Int J Mol Sci. 2022 Oct 28;23(21):13142. DOI: 10.3390/ijms232113142.
  36. Oliveira FR, Mamede M, Bizzi MF, Rocha ALL, Ferreira CN, Gomes KB, et al. Brown adipose tissue activity is reduced in women with polycystic ovary syndrome. Eur J Endocrinol. 2019 Nov, 181(5):473–80.
  37. Jaafar ZA, Salman DA, Obeid RZ. The role of maternal and fetal serum zinc level in low birth weight. Journal of Pharmaceutical Sciences and Research. 2018 Aug 1;10(8):211